Postprandial Effect of High-starch Meals in Individuals With Low and High Copy Number of the Salivary Amylase Gene

Sponsor
Lund University (Other)
Overall Status
Completed
CT.gov ID
NCT03974126
Collaborator
University of Copenhagen (Other)
23
1
2
6.5
3.5

Study Details

Study Description

Brief Summary

Individuals with low copy numbers of salivary amylase gene have lower salivary amylase levels and might therefore have decreased capacity to metabolize starch into glucose. We will in a randomized crossover meal study examine the postprandial response of high-starch meals in individuals with either low or high copy number of the salivary amylase gene.

Condition or Disease Intervention/Treatment Phase
  • Other: 40 grams of starch
  • Other: 80 grams of starch
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
23 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Participants with low and high copy numbers of AMY1 were randomized to either 40 or 80 grams of starch in a crossover design.Participants with low and high copy numbers of AMY1 were randomized to either 40 or 80 grams of starch in a crossover design.
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Masking Description:
Genotype were blinded for the participants and all research staff except for the principal investigator. Amount of bread was not blinded.
Primary Purpose:
Prevention
Official Title:
Postprandial Effect of High-starch Meals in Individuals With Low and High Copy Number of the Salivary Amylase Gene
Actual Study Start Date :
Apr 30, 2019
Actual Primary Completion Date :
Sep 19, 2019
Actual Study Completion Date :
Nov 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: 40 grams of starch to low and high AMY1 copy number carriers

The postprandial response between individuals that are either carriers of low AMY1 copy numbers (2-4) or high copy numbers (10 or more copies) will be compared

Other: 40 grams of starch
40 grams of starch in form of white bread to be consumed within 15 minutes

Experimental: 80 grams of starch to low and high AMY1 copy number carriers

The postprandial response between individuals that are either carriers of low AMY1 copy numbers (2-4) or high copy numbers (10 or more copies) will be compared

Other: 80 grams of starch
80 grams of starch in form of white bread to be consumed within 15 minutes

Outcome Measures

Primary Outcome Measures

  1. Postprandial glucose [AUC (0, 7, 15, 30, 45, 60, 90, 120 minutes)]

    Postprandial glucose concentration assessed as incremental area under curve over 120 minutes (0, 7, 15, 30, 45, 60 ,90, 120 minutes)

  2. Postprandial insulin [AUC (0, 7, 15, 30, 45, 60, 90, 120 minutes)]

    postprandial insulin concentration assessed as incremental area under curve over 120 minutes (0, 7, 15, 30, 45, 60 ,90, 120 minutes)

  3. Preabsorptive insulin release [7 minutes]

    Insulin concentration at 7 minutes

Secondary Outcome Measures

  1. subjective satiety [0, 15, 30, 45, 60, 90, 120 minutes]

    Visual analog scales (VAS) to evaluate hunger and satiety

  2. salivary amylase activity [0 minutes]

    Salivary amylase activity will be measured by ELISA kits

Other Outcome Measures

  1. weight [0 minutes]

    weight will be measured

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participant in the Malmö Offspring Study

  • Genotyped for AMY1 copy number variation and selected for having either low (2-4) or high (10 or above) copy number of AMY1

  • Gender: both males and females

  • Completed information on dietary habits

Exclusion Criteria:
  • Allergic to wheat, gluten intolerant or on a low-carbohydrate diet

  • Inability to eat up to 4 slices of white bread in 15 minutes

  • Use of medication known to influence glucose metabolism, appetite or saliva flow

  • Diagnosed diabetes or high fasting plasma glucose (above 6.1 mmol/L)

  • Smoking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lund University Lund Sweden 22100

Sponsors and Collaborators

  • Lund University
  • University of Copenhagen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lund University
ClinicalTrials.gov Identifier:
NCT03974126
Other Study ID Numbers:
  • Dnr 2018/968
First Posted:
Jun 4, 2019
Last Update Posted:
Jan 18, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 18, 2020